Answers are grounded in this paper and cite their sources.
In patients with severe Covid-19 not requiring mechanical ventilation, our trial did not show a significant difference between a 5-day course and a 10-day course of remdesivir. With no placebo control, however, the magnitude of benefit cannot be determined. (Funded by Gilead Sciences; GS-US-540-5773 ClinicalTrials.gov number, NCT04292899.).
No takes yet. Share an insight, caveat, or question.
Goldman et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: